The Food and Drug Administration (FDA) has granted traditional approval to Calquence (acalabrutinib) with bendamustine and Rituxan (rituximab) for adults with previously untreated mantle cell lymphoma ...

An international team of doctors led by Joshua Brody, MD, Director of the Lymphoma Immunotherapy Program at The Tisch Cancer ...

Findings showed acalabrutinib with bendamustine and rituximab (BR) reduced the risk of disease progression or death by 27% compared with placebo plus BR. The Food and Drug Administration (FDA) has ...

Confusion and anger were the first things Cell Max felt when emerging from his pod prematurely. Unable to tell friend from ...

In the open-label phase 2 LITESPARK-003 study, led by Dana-Farber Cancer Institute's Toni Choueiri, MD, researchers ...

FDA fully approves AstraZeneca's Calquence combo therapy, reducing MCL progression ... Get the Real Story Behind Every Major Earnings Report Mantle cell lymphoma (MCL) is a rare and typically ...

So in working with Dr. Dean Lee at Nationwide Children's Hospital in Columbus, Ohio, he was able to create a TGF-β-resistant natural killer cell. And so through using the healthy cells of ...

Share on Pinterest Do all our cells have a type of memory, and if so, how might this influence health? We investigate. Design by MNT; Photography by Grant Faint/Getty Images & Ed Reschke/Getty Images.

It feels like the Splinter Cell remake has been on its way for a while now, which isn't helped by the fact it's been over three years since we heard anything official about the game. From what we ...